Tumour necrosis factor-α and interleukin-1 and -6 in fibrocystic breast disease

By Herruzo A.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 2, 1999-03 ,pp. : 159-164

Springer Publishing Company

Access to resources Recommend Favorite

Structure-activity study with bioreductive benzoquinone alkylating agents: effects on DT-diaphorase-mediated DNA crosslink and strand break formation in relation to mechanisms of cytotoxicity

By Fourie Jeanne   Guziec Frank   Guziec Lynn   Monterrosa Cielo   Fiterman Derek   Begleiter Asher  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 3, 2004-03 ,pp. : 191-203

Springer Publishing Company

Access to resources Recommend Favorite

Defect of Tumour Necrosis Factor-α (TNF-α) Production and TNF-α-induced ICAM-1 – Expression in BRCA1 Mutations Carriers

By Zielinski C.C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 2, 2003-09 ,pp. : 99-105

Springer Publishing Company

Access to resources Recommend Favorite

The antitumour activity of alkylating agents is not correlated with the levels of glutathione, glutathione transferase and O 6 -alkylguanine-DNA-alkyltransferase of human tumour xenografts

By D'Incalci M.   Bonfanti M.   Pifferi A.   Mascellani E.   Tagliabue G.   Berger D.   Fiebig H.H.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1749-1755

Elsevier

Access to resources Recommend Favorite

Bendamustine as a model for the activity of alkylating agents

By Apostolopoulos Christos   Castellano Leandro   Stebbing Justin   Giamas Georgios  

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 323-332

Future Medicine

Access to resources Recommend Favorite